EQL Pharma
Slipp dessa annonser och få en massa andra godsaker med vårt
premiumabonnemang.
Fårö Capital divests further EQL shares to enable increased institutional ownership and create more liquidity in the share
Fårö has today sold 1 million shares to an institutional buyer base and after the sale owns 7,427 million shares corresponding to 25,5 % of the shares and capital.
| Datum | 2023-06-14, kl 10:10 |
| Källa | Cision |